| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/16/1995 | DE4406512C1 Integration vectors for producing genes which encode recombinant antibodies |
| 02/16/1995 | CA2168988A1 Polypeptides coded by exon v5 of the cd44 gene as targets for immunotherapy and immunoscintigraphy of tumours |
| 02/16/1995 | CA2168952A1 Prostatic cancer vaccine |
| 02/16/1995 | CA2166982A1 Human calcium channel compositions and methods using them |
| 02/16/1995 | CA2145767A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 02/15/1995 | EP0638648A2 Monoclonal antibodies specifically reacting with PAF receptor, production process thereof, and hybridomas producing the antibodies |
| 02/15/1995 | EP0638645A1 Human TRH receptor, its production and use |
| 02/15/1995 | EP0638644A1 Receptors of interleukin-12 and antibodies |
| 02/15/1995 | EP0638174A1 Measles virus-specific antibody detection using recombinant measles proteins. |
| 02/15/1995 | EP0638172A1 METHODS AND COMPOSITIONS FOR MONITORING CELLULAR PROCESSING OF $g(b)-AMYLOID PRECURSOR PROTEIN |
| 02/15/1995 | EP0638170A1 Rapid extraction of ciguatoxin from contaminated tissues |
| 02/15/1995 | EP0638126A1 Inhibitory factor |
| 02/15/1995 | EP0638092A1 Synthetic peptide vaccines for dental caries |
| 02/15/1995 | EP0638085A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 02/15/1995 | EP0638067A1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 02/15/1995 | EP0637963A1 Cd28 pathway immunoregulation |
| 02/15/1995 | EP0637933A1 Method and kit for imaging and treating organs and tissues |
| 02/15/1995 | EP0587780B1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 02/15/1995 | EP0368992B1 Actions of hormones |
| 02/14/1995 | US5389539 Purification of heparinase I, II, and III from Flavobacterium heparinum |
| 02/14/1995 | US5389530 Methods for the production of antibodies and induction of immune responses to tumor-associated ganagliosides by immunization with gangloiside lactones |
| 02/14/1995 | US5389528 Isolated DNA sequence encoding polypeptide identifiable as component of hepatitis delta antigen |
| 02/14/1995 | US5389527 DNA encoding mammalian phosphodiesterases |
| 02/14/1995 | US5389520 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/14/1995 | US5389518 Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof |
| 02/14/1995 | US5389517 Specific antibodies against the DNA-binding domain of and immunoassays to determine the presence and functional status of estrogen receptor proteins |
| 02/14/1995 | US5389516 Efficiency of colon chemotherapy |
| 02/11/1995 | CA2130210A1 Human trh receptor, its production and use |
| 02/09/1995 | WO1995004283A1 Reagents and methods for the detection and quantification of testosterone in fluid samples |
| 02/09/1995 | WO1995004282A1 Immunoassay for detecting collagen or collagen fragments |
| 02/09/1995 | WO1995004081A1 MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS |
| 02/09/1995 | WO1995004080A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | WO1995004079A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences |
| 02/09/1995 | WO1995004073A1 Type-2 angiotensin ii receptor and gene |
| 02/09/1995 | WO1995003834A1 PRE-BINDING OF RETROVIRAL VECTOR PARTICLES WITH COMPLEMENT COMPONENTS TO ENABLE THE PERFORMANCE OF HUMAN GENE THERAPY $i(IN VIVO) |
| 02/09/1995 | WO1995003832A1 Intracellular immunization |
| 02/09/1995 | WO1995003828A1 Single-chain immunotoxin compositions and methods for preventing secondary cataracts |
| 02/09/1995 | WO1995003827A1 Method for treating multiple sclerosis |
| 02/09/1995 | WO1995003826A1 Stabilised immunoglobulin preparations and method for preparing same |
| 02/09/1995 | WO1995003815A1 Antibodies specific to quinolinic acid |
| 02/09/1995 | WO1995003813A1 Novel eimeria antibodies and antigens and methods of using the same |
| 02/09/1995 | WO1995003770A1 Methods for b-cell population control |
| 02/09/1995 | WO1995003701A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | DE4322342A1 Method for the differential diagnosis of carcinoma of the prostate |
| 02/09/1995 | DE4320624A1 Method for the diagnosis and analysis of carcinomas of the breast |
| 02/09/1995 | DE4320623A1 Method for the diagnosis and analysis of adenocarcinomas |
| 02/09/1995 | CA2168428A1 Antibodies specific to quinolinic acid |
| 02/09/1995 | CA2168426A1 Recombinant vector containing a lipoprotein gene sequence expressing nucleotide sequences |
| 02/09/1995 | CA2168349A1 Intracellular immunization |
| 02/09/1995 | CA2168230A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | CA2168098A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | CA2167835A1 Monoclonal iga antibody against respiratory syncytial virus |
| 02/09/1995 | CA2167712A1 Process for preparing stabilized immunoglobulins |
| 02/09/1995 | CA2167533A1 Novel eimeria antibodies and antigens and methods of using the same |
| 02/09/1995 | CA2167496A1 Immunoassay for the detection of collagen or collagen fragments |
| 02/08/1995 | EP0637593A1 Bispecific trigger molecules recognizing lymphocyte antigen CD2 and tumor antigens |
| 02/08/1995 | EP0637336A1 Mn gene and protein |
| 02/08/1995 | EP0637334A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637253A1 Carboxamide modified polyamine chelators and radioactive complexes and conjugates |
| 02/07/1995 | US5387746 Pulmonary hydrophobic surfactant-associated protein of 6,000 daltons molecular weight and multimers thereof |
| 02/07/1995 | US5387676 MN gene and protein |
| 02/07/1995 | US5387504 Monospecific antibodies and assay system for detecting stromelysin cleavage products |
| 02/07/1995 | US5387414 Comprising peptide immunogen with novel epitopes |
| 02/07/1995 | US5387413 Anticoagulation by injecting a solution of a monoclonal antibody produced from hybridomas |
| 02/07/1995 | CA2103693A1 Animal model of the human immune system |
| 02/02/1995 | WO1995003547A1 Methods for determining the invasiveness of a bladder tumor |
| 02/02/1995 | WO1995003415A2 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003335A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | WO1995003334A1 Antibodies specific for human prostate glandular kallikrein |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003325A1 Protegrins |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003318A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | WO1995003296A1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 02/02/1995 | WO1995003069A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | WO1994029446A3 Intracellular binding proteins and use thereof |
| 02/02/1995 | WO1994029350A3 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/02/1995 | CA2168232A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | CA2168096A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | CA2167808A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2167267A1 Methods for determining the invasiveness of a bladder tumor |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166788A1 Protegrins |
| 02/02/1995 | CA2166782A1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 02/01/1995 | EP0636182A1 Antibodies for treatment and prevention of respiratory syncytial virus infection |
| 02/01/1995 | EP0636178A1 Protocadherin, their autibodies and uses |
| 02/01/1995 | EP0636177A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN $g(b) SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0636173A1 Treatment of hiv-associated immune thrombocytopenic purpura |
| 02/01/1995 | EP0636171A1 Methods of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells |
| 02/01/1995 | EP0636029A1 Antibodies specific for carcinoma-associated antigens |
| 02/01/1995 | EP0535150B1 Human macrophage inflammatory protein 2-beta |
| 02/01/1995 | EP0473649B1 Biologically active polypeptides based on transforming growth factor-beta sequences |
| 01/31/1995 | US5386013 A polypeptide glycoprotein having hyaluronic acid binding activity; antiinflammatory, antiarthritic, anticancer agents, infections |
| 01/31/1995 | US5385831 Genetic engineering; culturing eukaryotic cells, isolating, purification; diagnosis, immunoassays, autoimmune diseases |